Skip to main content

Finch Therapeutics Group, Inc.

FNCHDelisted Oct 31, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001733257

Finch Therapeutics Group, Inc. was delisted on Oct 31, 2024; its insiders filed their last Form 4 on Jun 10, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.

13F holders, Q1 2022

Institutional positions in Finch Therapeutics Group, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
53
+2 vs. Q4 2021
Shares held
10.6M
−978.9K (−8.5%) vs. Q4 2021
Total value
$53.1M
−$61.9M (−53.8%) vs. Q4 2021
New holders
4
9 more added
Sold out
2
20 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FNCH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 53 institutions
Q1 2021: 36 institutionsQ2 2021: 46 institutionsQ3 2021: 45 institutionsQ4 2021: 51 institutionsQ1 2022: 53 institutionsQ2 2022: 47 institutionsQ3 2022: 43 institutionsQ4 2022: 40 institutionsQ1 2023: 33 institutionsQ2 2023: 17 institutionsQ3 2023: 18 institutionsQ4 2023: 17 institutionsQ1 2024: 11 institutionsQ2 2024: 1 institutionQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $53.1M
Q1 2021: $108.9MQ2 2021: $77.2MQ3 2021: $106.8MQ4 2021: $115.0MQ1 2022: $53.1MQ2 2022: $28.0MQ3 2022: $16.8MQ4 2022: $4.60MQ1 2023: $3.75MQ2 2023: $2.16MQ3 2023: $1.37MQ4 2023: $754.7KQ1 2024: $338.2KQ2 2024: $29.1KQ3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding FNCH and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20241$29.1K
Q1 202411$338.2K
Q4 202317$754.7K
Q3 202318$1.37M
Q2 202317$2.16M
Q1 202333$3.75M
Q4 202240$4.60M
Q3 202243$16.8M
Q2 202247$28.0M
Q1 202253$53.1M
Q4 202151$115.0M
Q3 202145$106.8M
Q2 202146$77.2M
Q1 202136$108.9M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Finch Therapeutics Group, Inc.; share changes are against Q4 2021.

Institutions holding FNCH in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Susquehanna International Group, LLP1,770,858$8.91M0.01%00.0%Unchanged
Avenir Management Company, LLC1,663,366$8.37M7.65%00.0%Unchanged
Baupost Group LLCSuperinvestorBaupost Group1,123,108$5.65M0.06%−9,145−0.8%Reduced
Bleichroeder LP810,416$4.08M0.72%00.0%Unchanged
Vanguard Group Inc794,299$3.99M0.00%−2,649−0.3%Reduced
Lake Street Advisors Group, LLC739,136$3.72M0.24%00.0%Unchanged
Light Street Capital Management, LLC668,757$3.36M0.26%−142,974−17.6%Reduced
TRB Advisors LP570,000$2.87M1.57%00.0%Unchanged
BlackRock Inc.404,931$2.04M0.00%+9,149+2.3%Added
MSD Partners, L.P.388,691$1.96M0.12%−777,382−66.7%Reduced
Ikarian Capital, LLC330,523$1.66M0.51%+14,791+4.7%Added
Aperture Investors, LLC195,229$982.0K0.13%00.0%Unchanged
Geode Capital Management, LLC160,425$806.0K0.00%+9,263+6.1%Added
Ballentine Partners, LLC143,603$722.0K0.02%00.0%Unchanged
Proficio Capital Partners LLC110,559$556.0K0.08%00.0%Unchanged
State Street Corp109,194$549.0K0.00%+2,975+2.8%Added
Northern Trust Corp64,821$326.0K0.00%−2,624−3.9%Reduced
Citadel Advisors LLC59,715$300.0K0.00%−17,609−22.8%Reduced
Laurion Capital Management LP58,000$292.0K0.01%00.0%Unchanged
Charles Schwab Investment Management Inc54,950$277.0K0.00%−2,761−4.8%Reduced
Renaissance Technologies LLC45,000$226.0K0.00%+7,314+19.4%Added
SCS Capital Management LLC38,294$193.0K0.00%00.0%Unchanged
Qube Research & Technologies Ltd37,631$189.0K0.00%+13,128+53.6%Added
Boothbay Fund Management, LLC32,033$161.0K0.01%00.0%Unchanged
Morgan Stanley25,773$129.0K0.00%−1,638−6.0%Reduced
Bank of New York Mellon Corp25,037$126.0K0.00%−565−2.2%Reduced
Ergoteles LLC19,002$96.0K0.00%−44,879−70.3%Reduced
D. E. Shaw & Co., Inc.19,170$96.0K0.00%−8,274−30.1%Reduced
HighTower Advisors, LLC18,099$91.0K0.00%00.0%Unchanged
Ancora Advisors, LLC15,746$79.0K0.00%+3,800+31.8%Added
Nuveen Asset Management, LLC12,002$64.0K0.00%00.0%Unchanged
New York State Common Retirement Fund6,576$33.0K0.00%00.0%Unchanged
Bank of America Corp5,486$27.0K0.00%−8,892−61.8%Reduced
Deutsche Bank AG4,105$21.0K0.00%−478−10.4%Reduced
American International Group, Inc.3,758$19.0K0.00%−263−6.5%Reduced
JPMorgan Chase & Co3,550$18.0K0.00%−1,270−26.3%Reduced
Tower Research Capital LLC (TRC)3,338$17.0K0.00%+1,863+126.3%Added
California State Teachers Retirement System3,184$16.0K0.00%−863−21.3%Reduced
Captrust Financial Advisors3,175$16.0K0.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC2,250$11.0K0.00%00.0%Unchanged
STRS Ohio1,800$9.00K0.00%00.0%Unchanged
Wells Fargo & Company1,580$8.00K0.00%−2,633−62.5%Reduced
Barclays PLC1,336$7.00K0.00%+1,336New
UBS Group AG1,204$6.00K0.00%−3,986−76.8%Reduced
Amalgamated Bank942$5.00K0.00%+942New
Amalgamated Financial Corp.942$5.00K0.00%+942New
Legal & General Group Plc603$3.00K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.593$3.00K0.00%00.0%Unchanged
Northwestern Mutual Wealth Management Co600$3.00K0.00%00.0%Unchanged
Citigroup Inc322$2.00K0.00%−1,555−82.8%Reduced
Royal Bank of Canada465$2.00K0.00%−1,179−71.7%Reduced
FMR LLC47$00.00%+47New
Advisor Group Holdings, Inc.41––+10+32.3%Added
Millennium Management LLC0$00.00%−12,642−100.0%Sold out
Lazard Asset Management LLC0$00.00%−150−100.0%Sold out